Yahoo Suche Web Suche

Suchergebnisse

  1. Suchergebnisse:
  1. Anne Wojcicki erwarb 1996 einen Bachelor -Abschluss in Biologie von der Yale University und arbeitete dann zehn Jahre als Analystin, spezialisiert auf Biotechnologiefirmen. 2006 gründete sie mit Linda Avey und anderen die Firma für Gentests 23andMe in Mountain View. [1]

  2. Anne E. Wojcicki (/ w uː ˈ tʃ ɪ t s k i / woo-CHITS-kee; born July 28, 1973) is an American entrepreneur who co-founded and is CEO of the personal genomics company 23andMe. She founded the company in 2006 with Linda Avey and Paul Cusenza. She is a co-founder and board member of the Breakthrough Prize.

    • Co-founder and CEO of 23andMe
  3. www.forbes.com › profile › anne-wojcickiAnne Wojcicki - Forbes

    1. Juni 2023 · Anne Wojcicki is the cofounder and CEO of 23andMe, a direct-to-consumer genetics testing firm that went public in 2021. She is the sister of YouTube's former CEO Susan Wojcicki and has a net worth of $270 million as of 2023.

  4. 9. Mai 2024 · Anne Wojcicki is an American entrepreneur and cofounder and chief executive officer of the personal genetics company 23andMe. Wojcicki received a B.S. degree (1996) in biology from Yale University. She later worked as a researcher and as an investment analyst. In 2006, while pursuing her interest.

  5. 20. Mai 2021 · Listen to Anne Wojcicki, CEO of 23andMe, a DNA testing and analysis company, talk about her goals, challenges, and opportunities in an emerging industry. She discusses how 23andMe helps individuals and researchers with personalized medical care and genetic research.

  6. 25. Apr. 2023 · Anne Wojcicki is the co-founder and CEO of 23andme. Jordan Vonderhaar—Bloomberg/Getty Images. Sequencing the human genome for the first time was an incredible feat. Twenty years ago this week,...

  7. CEO and Co-Founder. Anne co-founded 23andMe in 2006, three years after the first human genome was sequenced. Her goal was audacious: to help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process.